Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: Analysis of the first five million prescriptions in 1999

European Journal of Clinical Pharmacology

Volumn 59, Issue 8-9, 2003, Pages 689-695

  Guédon Moreau, Laurence ^a   Ducrocq, Dominique ^b   Duc, Marie Francoise ^c   Quieureux, Yves ^b   L'Hôte, Catherine ^d   Deligne, Jean ^e   Caron, Jacques ^a  

^a UNIV LILLE   (France)

^b Assurance Maladie   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d Echelon Rég du Serv Medical ^*  (France)

^e Assur Malad Professions I   (France)

Author keywords

Adverse drug reactions; Drug interactions; Prescriptions

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMIGRAINE AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; DEXTROMETHORPHAN; DIGITALIS; ERGOT ALKALOID; FLOCTAFENINE; IMIDAZOLE DERIVATIVE; INDINAVIR; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OPIATE; ORAL CONTRACEPTIVE AGENT; PETHIDINE; PROKINETIC AGENT; RETINOID; RITONAVIR; SAQUINAVIR; SUMATRIPTAN; TRAMADOL; TRIAZOLAM; UNINDEXED DRUG;

AGITATION; ANAPHYLACTIC SHOCK; ARTICLE; BLEEDING; COMA; CONFUSION; CORONARY ARTERY CONSTRICTION; DATA BASE; DIARRHEA; DRUG CONTRAINDICATION; DRUG METABOLISM; DRUG SAFETY; ERGOTISM; FRANCE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPERTHERMIA; HYPOGLYCEMIA; INTRACRANIAL HYPERTENSION; LONG QT SYNDROME; MAJOR CLINICAL STUDY; NEPHROTOXICITY; OTOTOXICITY; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RHABDOMYOLYSIS; RISK ASSESSMENT; SEDATION; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SWEATING; TACHYCARDIA; TISSUE NECROSIS; TORSADE DES POINTES; TREMOR; WITHDRAWAL SYNDROME;

DRUG INTERACTIONS; OUTPATIENTS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE;

EID: 0345166080     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0684-1     Document Type: Article

References (32)

1. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospectives studies. JAMA 279:1200-1205
2. Fattinger K, Roos M, Vergères P, et al. (2000) Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. J Clin Pharmacol 49: 158-167
3. Borda JP, Sloan D, Jick H (1968) Assessment of adverse reactions within a drug surveillance program. JAMA 205:645-647
4. Boston Collaborative Drug Surveillance Program (1972) Adverse drug reactions. JAMA 220:1238-1239
5. Mok H, Mulpeter K, Oconnor P, Feely J (1991) Drug-drug interactions in the hospital. Irish Med J 84:26
6. Stanton LA, Peterson GM, Rumble RH (1994) Drug-related admissions to an Australian hospital. J Clin Pharmacol Ther 19:341-347
7. Steven ID, Malpass A, Moller J, Runciman WB, Helps SC (1999) Towards safer drug use in general practice. J Qual Clin Practice 19:47-50
8. Beers MH, Storrie M, Lee G (1990) Potential adverse drug interactions in the emergency room. Ann Intern Med 112:61-64
9. Jankel CA, Fitterman LK (1993) Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 9:51-59
10. Classen K, Pestonik S, Evans S, Lloyd J, Burke J (1997) Adverse drug events in hospitalised patients excess length of stay, extra costs, and attributable mortality. JAMA 227:301-306
11. Adson DE, Crow SJ, Meller WH, Magraw RM (1998) Potential drug-drug interactions on a tertiary-care hospital consultation-liaison psychiatry service. Psychosomatics 39:360-365
12. Cadieux RJ (1989) Drug interactions in the elderly: how multiple drug use increases risk exponentially. Postgrad Med 86:179-186
13. Costa AJ (1991) Potential drug interactions in an ambulatory geriatric population. Fam Pract 8:234-236
14. Goldberg RM, Mabee J, Chan L, Wong S (1996) Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 14:447-450
15. Hamilton RA, Gordon T (1992) Incidence and cost of hospital admissions secondary to drug interactions involving theophyl-line. Ann Pharmacother 26:1507-1511
16. Hansten PD (1991) Drug interactions with antisecretory drugs. Aliment Pharmacol Ther 5[Suppl 1]:121-128
17. Jankel CA, McMillan JA, Martin BC (1994) Effect of drug interactions on outcomes of patients receiving warfarin or theophylline. Am J Hosp Pharm 51:661-666
18. Johnson Z, Dack P (1992) Prescribing patterns for combinations of warfarin and potentially dangerous interacting drugs in a large general practice population. Pharmacoepidemiol Drug Saf 1:119-123
19. Gouveia WA, Miller RR (1978) Drug interaction screening. A screen or a sieve? Am J Hosp Pharm 35:667
20. Jinks MJ, Hansten PD, Hirschman JL (1979) Drug interaction exposure in an ambulatory medicaid population. Am J Hosp Pharm 36:923-927
21. Linnarson R (1993) Drug interactions in primary health care. A retrospective database study and its implications for the design of a computerized decision support system. Scand J Prim Health Care 11:181-186
22. Mitchell GW, Stanaszek WF, Nichois NB (1979) Documenting drug-drug interactions in ambulatory patients. Am J Hosp Pharm 36:653-657
23. Paille F, Pissochet P (1995) Drug interactions in primary health care: prospective study of 896 patients treated for hypertension. Therapie 50:253-258
24. Paulet N, Bury PC, Needleman M, Raymond K (1982) Drug interactions. A study and evaluation of their incidence in Victoria. Med J Aust 1:80-81
25. Remy N, Lapeyre-Mestre M, Bareille MP, Bagheri H, Montastruc JL (2000) Drug interactions: a prospective pilot study in primary health care. Therapie 55:395-398
26. Shinn AF, Shrewsbury RB, Anderson KW (1983) Development of a computerized drug interaction database (Medicom) for use in a patient specific environment. Drug Inf J 17:205-210
27. Anonymous (1999) Dictionnaire Vidal. Editions du Vidal, Paris (http://www.vidalpro.net/)
28. Seroussi B, Gerondeau N, Morice V, Boisvieux JF (1997) Comparative evaluation of French drug data banks. Therapie 52:207-212
29. Jankel CA, Speedie SM (1990) Detecting drug interactions: a review of the literature. Ann Pharmacother 24:982-989
30. Vargas E, Navarro MI, Laredo L, Garcia-Arenillas M, Garcia-Mateos M, Moreno A (1997) Effect of drug interactions on the development of adverse drug reactions. Clin Drug Invest 13:282-289
31. Comet D, Casajuana J, Bordas JM, Fuentes MAAJA, Nunez B, Pou R (1997) Drug interactions in chronic prescription. Study in four primary care centers. Atencion Primaria 20:31-34
32. Davidson KW, Kahn A, Price RD (1987) Reduction of adverse drug reactions by computerized drug interaction screening. J Fam Pract 25:371-375